Neurology/Psychiatry Exam #3 (ADHD/MS)
.
- 1.Fill in the blanks: According to the DSM-V (through future-magic) the diagnosis of ADHD in patient <17 years old requires ______ symptoms and the diagnosis of ADHD in patients >17 years old requires ______ symptoms.
- A.
4 symptoms; 4 symptoms
- B.
4 symptoms; 5 symptoms
- C.
4 symptoms; 6 symptoms
- D.
5 symptoms; 4 symptoms
- E.
5 symptoms; 5 symptoms
- F.
5 symptoms; 6 symptoms
- G.
6 symptoms; 4 symptoms
- H.
6 symptoms; 5 symptoms
- I.
6 symptoms; 6 symptom
- 2.Genetics plays a significant role in ADHD etiology.
- A.
True
- B.
False
- 3.>70% of cases are genes associated with ADHD
- A.
True
- B.
False
- 4.Which neurotransmitters are KNOWN to be involved in ADHD? (Select all that apply)
- A.
Dopamine
- B.
Norepinephrine
- C.
Serotonin
- D.
GABA
- E.
Acetylcholine
- 5.Methylphenidate (MPD) decreases dopamine and norepinephrine levels by inhibiting monoamine transporters. Specifically, decreasing dopamine causes improved signal-to-noise ratio improving attention span.
- A.
True
- B.
False
- 6.Which medication blocks dopamine transporters, preventing uptake from the synaptic cleft?
- A.
Amphetamine
- B.
Methlyphenidate
- C.
All of the above
- 7.Which medication increases synaptic cleft levels of dopamine?
- A.
Amphetamine
- B.
Methylphenidate
- C.
All of the above
- 8.In addition to dopamine modification, what effect do Amphetamine and Methlyphenidate have on neuroanatomy of Norepinephrine neurons?
- A.
Suppress locus coeruleus NE neurons
- B.
Activate locus coeruleus NE neurons
- C.
Suppress decimus meridius NE neurons
- D.
Activate decimus meridius NE neurons
- 9.Which qualities of bupropion (Wellbutrin) is FALSE?
- A.
Selective Norepinephrine reuptake inhibitor
- B.
Used mainly in adults
- C.
Lacks potential for abuse
- D.
Does have risk of seizures
- 10.Which of the following is TRUE about Atomoxetine (Strattera)?
- A.
Up to 3 weeks (5 half lives) to have full effect
- B.
Moderate potential for abuse
- C.
Only drug approved by the FDA for adult ADHD
- D.
Requires multiple daily dosing at maintenance levels
- 11.Alpha-2-Adrenoceptor agonists (clonidine and guanfacine) _____ NE release in the locum coeruleus
- A.
Stimulate
- B.
Inhibit
- 12.Which Methylphenidate mediation has an osmotic release, which extends its effect up to 12 hours?
- A.
Strattera
- B.
Concerta
- C.
Vyvanse
- D.
Daytrana
- 13.The transdermal methylphenidate patch is as effective as other formulations
- A.
True
- B.
False
- 14.Focalin (or Dexmethlyphenidate) contains only the d-isomer of methylphenidate. As a result, the dose is 50% lower than methylphenidate and while efficacy is the same, tolerability of the medication is increased.
- A.
True
- B.
False
- 15.Which of the follow would NOT be consider a common, specific adverse effect of stimulants?
- A.
Anorexia
- B.
Ataxia
- C.
Headache
- D.
Mood changes
- 16.When would atomoxetine (Strattera) NOT be an alternative 1st line treatment?
- A.
Anxiety disorder
- B.
Intolerance to methylphenidate
- C.
Metabolic disease
- D.
Substance abuse disorder
- 17.Which of the follow is not a precaution in use of atomoxetine (Strattera)?
- A.
Blood dyscrasia
- B.
Liver injury
- C.
Urinary retention
- D.
Suicidal ideation
- 18.What is the starting/titration dose of atomoxetine (Straterra)?
- A.
0.1 mg/kg/day
- B.
0.5 mg/kg/day
- C.
1 mg/kg/day
- D.
5 mg/kg/day
- 19.When treatment with Stimulants results in increased tics, treatment for ADHD with clonidine (catapres) can be considered.
- A.
True
- B.
False
- 20.Within how long is typical onset of guanfacine treatment in ADHD experienced?
- A.
- B.
- C.
- D.
- 21.Which of the following statements about ADHD in children is FALSE?
- A.
90% respond to stimulant(s) alone
- B.
Long-acting formulations are more preferred
- C.
Lower doses for hyperactive type ADHD, higher doses for inattentive or combined form
- D.
Medications are best studied in this age group
- 22.In treatment of major depressive disorder in pediatric patients, combination cognitive behavior therapy and SSRI are better than either treatment alone
- A.
True
- B.
False
- 23.Which of the following SSRI is NOT expert recommended in treatment of major depressive disorder in pediatric patients?
- A.
Fluoxetine
- B.
Citalopram
- C.
Sertraline
- D.
Paroxetine
- 24.Which of the following is NOT a characteristic of Autism Spectrum Disorders?
- A.
Delusions
- B.
Impaired nonverbal/verbal communication
- C.
Impaired social interactions
- D.
Repetitive behaviors
- 25.Which medication is FDA approved as a pharmacologic option for Autism Spectrum Disorders?
- A.
Atomoxetine
- B.
Clonidine
- C.
Guanficine
- D.
Risperidone
Questions: 8 | Attempts: 18012 | Last updated: Jul 9, 2021
-
Sample QuestionFirst of all, have you ever suffered from any chronic disease?
Questions: 9 | Attempts: 6343 | Last updated: May 3, 2019
-
Sample QuestionHow Would You Describe Yourself?
Questions: 10 | Attempts: 4395 | Last updated: Nov 27, 2020
-
Sample QuestionWhen you go into any room with other people what is racing threw your head?
Back to top